Cargando…

Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis

The efficacy and safety of immune‐checkpoint inhibitors in non‐small cell lung cancer patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Herein, we describe the case of a 62‐year‐old man with multiple pleural tumors and carcinomatous pleurisy. High‐resolution computed tomography indic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ide, Maako, Tanaka, Kentaro, Sunami, Shunya, Asoh, Tatsuma, Maeyama, Takashige, Tsuruta, Nobuko, Nakanishi, Yoichi, Okamoto, Isamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209776/ https://www.ncbi.nlm.nih.gov/pubmed/30152594 http://dx.doi.org/10.1111/1759-7714.12853

Ejemplares similares

Idiopathic Pulmonary Fibrosis Complicated by Adenocarcinoma and Organizing Pneumonia
por: Inutsuka, Yu, et al.
Publicado: (2022)

A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Origin
por: Takatsuki, Kensaku, et al.
Publicado: (2021)

A Case of Drug-Induced Interstitial Lung Disease Caused by Epirubicin and Cyclophosphamide Therapy Before Breast Cancer Surgery
por: Egashira, Ayaka, et al.
Publicado: (2021)

Early Recognition and Treatment of Relapsing Polychondritis
por: Yanagihara, Toyoshi, et al.
Publicado: (2022)

Three cases of sequential treatment with nintedanib following pulsed-dose corticosteroids for acute exacerbation of interstitial lung diseases
por: Nakashima, Kazuki, et al.
Publicado: (2021)

A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis
por: Nakashima, Kazuki, et al.
Publicado: (2021)

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry
por: Tsubouchi, Kazuya, et al.
Publicado: (2023)

Successful treatment with mepolizumab for allergic bronchopulmonary mycosis complicated with bilateral septic arthritis of the knee joints caused by Methicillin-resistant Staphylococcus aureus
por: Yanagihara, Toyoshi, et al.
Publicado: (2020)

Pulmonary amyloidosis complicated with pulmonary hemosiderosis, diagnosed with bronchoscopy
por: Ogo, Naruhiko, et al.
Publicado: (2021)

Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease
por: Ohgushi, Migiwa, et al.
Publicado: (2021)

Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease‐free survival in individuals with non‐small cell lung cancer
por: Ando, Nobuhisa, et al.
Publicado: (2020)

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis
por: Yoneshima, Yasuto, et al.
Publicado: (2021)

Paired genetic analysis by next‐generation sequencing of lung cancer and associated idiopathic pulmonary fibrosis
por: Otsubo, Kohei, et al.
Publicado: (2020)

Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies
por: Yanagihara, Toyoshi, et al.
Publicado: (2020)

A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy
por: Sugahara, Kaho, et al.
Publicado: (2021)

Depletion of club cells attenuates bleomycin-induced lung injury and fibrosis in mice
por: Yokoyama, Tetsuya, et al.
Publicado: (2017)

Lenvatinib for poorly differentiated carcinoma of the anterior mediastinum
por: Yanagihara, Toyoshi, et al.
Publicado: (2021)

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor–naïve patients with non–small cell lung cancer harboring EGFR mutations
por: Tanaka, Kentaro, et al.
Publicado: (2017)

Efficacy and Safety of Sitafloxacin in Treating Low-risk Febrile Neutropenia in Patients with Lung Cancer
por: On, Rintaro, et al.
Publicado: (2022)

Acute Cerebellar Ataxia Induced by Nivolumab
por: Kawamura, Reina, et al.
Publicado: (2017)

Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2021)

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab
por: Khunger, Monica, et al.
Publicado: (2017)

A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient
por: Yatsuda, Yukino, et al.
Publicado: (2020)

Probucol attenuates hyperoxia-induced lung injury in mice
por: Kawaguchi, Tomonobu, et al.
Publicado: (2017)

Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report
por: Lepir, Tanja, et al.
Publicado: (2019)

Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma
por: Cabezas-Camarero, Santiago, et al.
Publicado: (2022)

Improvement of urinary symptoms after bladder biopsy: A case of pathologically proven allergy‐related cystitis during administration of nivolumab
por: Yajima, Shugo, et al.
Publicado: (2021)

Visualization and quantitation of epidermal growth factor receptor homodimerization and activation with a proximity ligation assay
por: Ota, Keiichi, et al.
Publicado: (2017)

Sensitivity of epidermal growth factor receptor with single or double uncommon mutations to afatinib confirmed by a visual assay
por: Kimura, Shinichi, et al.
Publicado: (2018)

Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis
por: Kudo, Fumiaki, et al.
Publicado: (2018)

Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab
por: Kawashima, Yosuke, et al.
Publicado: (2019)

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
por: Iwama, Eiji, et al.
Publicado: (2014)

Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non–small cell lung cancer (WJOG 5910L)
por: Takeda, Masayuki, et al.
Publicado: (2012)

Bax-inhibiting peptide attenuates bleomycin-induced lung injury in mice
por: Suzuki, Kunihiro, et al.
Publicado: (2017)

Tracheobronchial Chondritis Associated with Immune Checkpoint Blockade
por: Asoh, Tatsuma, et al.
Publicado: (2021)

An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic Adenocarcinoma
por: Costa, Rubens Barros, et al.
Publicado: (2018)

The Significant Antitumor Activity of Nivolumab in Lung Adenocarcinoma with Choriocarcinomatous Features
por: Ochi, Mieko, et al.
Publicado: (2018)

Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma
por: Shah, Suma, et al.
Publicado: (2018)

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
por: Birnbaum, Mathew R., et al.
Publicado: (2017)

Durable tumor regression in highly refractory metastatic KIT/PDGFRA wild-type GIST following treatment with nivolumab
por: Schroeder, Brett A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fv1r1f3ctl36ffbcppnd73cn2h